Founded in 2016, Spindiag is a spin-off from the renowned Hahn-Schickard research institute. It is a young and innovative medical technology start-up with a highly motivated and continuously growing team of over 100 employees. Spindiag brings together expertise from science, research & development, production, marketing, quality, sales, and services, supported by external advisors.

Spindiag’s mission is to equip the world with effective tools against epidemic and pandemic infectious diseases. Their flagship product, the Rhonda point-of-care testing system, delivers reliable in-vitro diagnostic PCR results in less than one hour. Rhonda is designed to improve patient safety by becoming the new gold standard for routine infection control, providing healthcare workers with a safe, simple, and efficient solution.

In 2020, Spindiag launched a rapid point-of-care PCR test for SARS-CoV-2 detection. The company is committed to improving global health by providing timely and accurate diagnostic results.